Article
Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine.
The Tohoku journal of experimental medicine - 1 Aug 2020
Kukimoto Iwao, Matsumoto Koji, Takahashi Fumiaki, Iwata Takashi, Tanaka Kohsei, Yamaguchi-Naka Mayuko, Yamamoto Kasumi, Yahata Hideaki, Nakabayashi Makoto, Kato Hisamori, Tsuda Naotake, Onuki Mamiko, Yaegashi Nobuo
Abstract excerpt
In Japan, a bivalent human papillomavirus (HPV) vaccine against carcinogenic HPV16/18 was licensed in 2009, and a quadrivalent vaccines against HPV16/18 and non-carcinogenic HPV6/11 was licensed in 2011. Recently, the next-generation 9-valent vaccine targeting HPV6/11/16/18/31/33/45/52/58 has been approved. Accurate HPV genotyping is essential for HPV vaccine research and surveillance. The Roche Linear Array (LA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
